Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36322844

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Nov 3
First author
Castellino SM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Nov 3;387(18):1710-1712. doi: 10.1056/NEJMe2211587.
    note
    Source null
    related pmid
    36322850
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2023 Jan;20(1):2. doi: 10.1038/s41571-022-00715-0.
    note
    Source null
    related pmid
    36418475
    relationship
    Comment in

Authors and identifiers

  1. name
    Castellino SM
    type
    Author
  2. name
    Pei Q
    type
    Author
  3. name
    Parsons SK
    type
    Author
  4. name
    Hodgson D
    type
    Author
  5. name
    McCarten K
    type
    Author
  6. name
    Horton T
    type
    Author
  7. name
    Cho S
    type
    Author
  8. name
    Wu Y
    type
    Author
  9. name
    Punnett A
    type
    Author
  10. name
    Dave H
    type
    Author
  11. name
    Henderson TO
    type
    Author
  12. name
    Hoppe BS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Castellino SM
    type
    Author
  2. name
    Pei Q
    type
    Author
  3. name
    Parsons SK
    type
    Author
  4. name
    Hodgson D
    type
    Author
  5. name
    McCarten K
    type
    Author
  6. name
    Horton T
    type
    Author
  7. name
    Cho S
    type
    Author
  8. name
    Wu Y
    type
    Author
  9. name
    Punnett A
    type
    Author
  10. name
    Dave H
    type
    Author
  11. name
    Henderson TO
    type
    Author
  12. name
    Hoppe BS
    type
    Author
bibliography ids
  1. nci-bib-cf50fcbfdc0b0cfed8564908
book metadata
content sha256
122ab8d3c1827c6ba042267571623f0f3153a038e59e37dda952047d19cc21de
document type
citation
dois
  1. 10.1056/NEJMoa2206660
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:36322844
immutable id
pubmed:36322844@122ab8d3c1827c6ba042267571623f0f3153a038e59e37dda952047d19cc21de
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
18
name
The New England journal of medicine
nlm unique id
0255562
pages
1649-1660
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Nov 3;387(18):1710-1712. doi: 10.1056/NEJMe2211587.
    note
    Source null
    related pmid
    36322850
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2023 Jan;20(1):2. doi: 10.1038/s41571-022-00715-0.
    note
    Source null
    related pmid
    36418475
    relationship
    Comment in
outcomes validated
false
pmid
36322844
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
a9cf150eb1fd9f44d5ea4535521bf727dc5ef571ea0e92b6b60c09bcd62f5386
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2022 Nov 3
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36322844/
title
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.

Preserved source evidence · Not medical advice